Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA interference (RNAi) in hematology.

M Scherr1, D Steinmann, M Eder

  • 1Department of Hematology and Oncology, Hannover Medical School, Carl-Neuberg Strasse 1, 30625 Hannover, Germany. M.Scherr@t-online.de

Annals of Hematology
|October 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Bone marrow transplantation·2026
Same author

Characteristics of persons with varying vaccination personas: data from the CDC-funded PANDEMIC project.

Discover public health·2025
Same author

Immune checkpoint inhibitors therapy for solid organ malignancies after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT Transplant Complications Working Party.

Bone marrow transplantation·2024
Same author

Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO).

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2021
Same author

Timing of re-irradiation in recurrent high-grade gliomas: a single institution study.

Journal of neuro-oncology·2018
Same author

Acquired long QT syndrome during conditioning for allogeneic stem cell transplantation-are we aware of this side effect?

Annals of hematology·2018
Same journal

Clonal evolution of mycosis fungoides into peripheral T-cell lymphoma: evidence from next-generation sequencing in two cases.

Annals of hematology·2026
Same journal

Delayed-onset parkinsonism possibly associated with elranatamab treatment for relapsed/refractory multiple myeloma: a case report of a poorly characterized neurological event.

Annals of hematology·2026
Same journal

Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective study.

Annals of hematology·2026
Same journal

Flow cytometric analysis of T-cell subsets and platelet surface markers in patients with immune thrombocytopenia: a case-control study.

Annals of hematology·2026
Same journal

Lactate dehydrogenase (LDH) as a predictor of left atrial remodeling in patients with sickle cell anemia.

Annals of hematology·2026
Same journal

Pedigree analysis of cerebral venous sinus thrombosis associated with compound heterozygous hereditary protein S deficiency.

Annals of hematology·2026
See all related articles

RNA interference (RNAi) uses small interfering RNAs (siRNAs) for gene silencing. Understanding siRNA kinetics is crucial for therapeutic applications, especially in hematopoietic cells.

Area of Science:

  • Molecular Biology
  • Genetics

Background:

  • RNA interference (RNAi) is a conserved mechanism for post-transcriptional gene silencing.
  • Small interfering RNAs (siRNAs) trigger RNAi by degrading specific messenger RNAs (mRNAs).
  • RNAi has evolved into a powerful tool for functional genomics and therapeutic interventions.

Purpose of the Study:

  • To review key aspects of siRNA design and delivery for RNAi applications.
  • To discuss the kinetics of RNAi-induced gene silencing in mammalian cells.
  • To explore potential RNAi targets in hematopoietic cells for research and therapy.

Main Methods:

  • Literature review of RNAi mechanisms, siRNA design, and delivery strategies.
  • Analysis of kinetic factors influencing siRNA-mediated gene silencing.

Related Experiment Videos

  • Identification of therapeutic targets in hematopoietic cells.

    • Main Results:

    • siRNAs are effective for sequence-specific gene knockdown across various cell types.
    • Intracellular siRNA levels critically influence RNAi kinetics in mammalian cells.
    • Hematopoietic cells present specific targets for RNAi-based functional and therapeutic studies.

    Conclusions:

    • Effective siRNA design and delivery are essential for successful gene silencing.
    • Consideration of RNAi kinetics is vital for optimizing analytical and therapeutic applications.
    • RNAi holds significant potential for investigating and treating diseases in hematopoietic cells.